Celularity Inc. Announces $30 Million Private Placement Priced At-The-Market Under Nasdaq Rules
FLORHAM PARK, N.J., May 18, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived...